Skip to main content
. 2022 Oct 17;11(20):e026236. doi: 10.1161/JAHA.122.026236

Table 2.

Index TEER Procedure Characteristics

TEER procedure details Mitral surgery (N=44) Medical therapy (N=98) P value
Etiology of MR
Primary, n (%) 23 (52.3) 52 (53.1) 0.93
Secondary, n (%) 6 (13.6) 14 (14.3) 0.92
Mixed primary/secondary, n (%) 15 (34.1) 32 (32.6) 0.87
Number of TEER devices
1 clip implanted, n (%) 26 (59.2) 49 (50.0) 0.32
2 clips implanted, n (%) 18 (40.8) 49 (50.0) 0.32
Post‐TEER deployment
≤Moderate MR, n (%) 36 (81.8) 86 (87.8) 0.35
Mitral gradient, mm Hg 4.6±2.2 4.0±1.8 0.13
Tricuspid regurgitation
Moderate, n (%) 10 (22.7) 23 (23.4) 0.92
Severe, n (%) 6 (13.6) 20 (20.4) 0.33

MR indicates mitral regurgitation; and TEER, transcatheter edge‐to‐edge repair.